GrowingStockReport.com

NASDAQ Gainers Watch List: Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) and TrovaGene, Inc. (NASDAQ:TROV) Added to Growing Stock Report's NASDAQ Gainers Watch List

 

New York, NY -- (ReleaseWire) -- 03/27/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) and TrovaGene, Inc. (NASDAQ:TROV).

Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) a development-stage pharmaceutical company that focuses on the acquisition, development, and commercialization of pharmaceutical products is currently up (+7.86%) on 3,816,086 shares traded. Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) is currently up (+210%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Chelsea Therapeutics International Ltd. (NASDAQ:CHTP)

TrovaGene, Inc. (NASDAQ:TROV) a development stage molecular diagnostic company that focuses on developing and marketing urine-based nucleic acid tests for patient/disease screening and monitoring in the United States is currently up (+5.04%) on 130,330 shares traded after Trovagene Launches Urine-Based HPV Test. TrovaGene, Inc. (NASDAQ:TROV) is currently up (+259.68%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about TrovaGene, Inc. (NASDAQ:TROV)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com